A detailed history of Alliancebernstein L.P. transactions in Amgen Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,396,356 shares of AMGN stock, worth $368 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,396,356
Previous 1,557,810 10.36%
Holding current value
$368 Million
Previous $487 Million 7.56%
% of portfolio
0.16%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $50 Million - $54.5 Million
-161,454 Reduced 10.36%
1,396,356 $450 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $104 Million - $126 Million
-395,420 Reduced 20.24%
1,557,810 $487 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $28.6 Million - $34.6 Million
-106,541 Reduced 5.17%
1,953,230 $555 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $66.2 Million - $74.6 Million
258,730 Added 14.37%
2,059,771 $593 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $11.7 Million - $14.5 Million
-53,320 Reduced 2.88%
1,801,041 $484 Million
Q2 2023

Aug 15, 2023

SELL
$214.27 - $253.37 $13.1 Million - $15.5 Million
-61,181 Reduced 3.19%
1,854,361 $412 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $13.8 Million - $16.9 Million
-61,327 Reduced 3.1%
1,915,542 $463 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $21.2 Million - $26.9 Million
-92,587 Reduced 4.47%
1,976,869 $519 Million
Q3 2022

Nov 15, 2022

SELL
$224.46 - $253.15 $8.94 Million - $10.1 Million
-39,811 Reduced 1.89%
2,069,456 $466 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $22.2 Million - $24.7 Million
-96,170 Reduced 4.36%
2,109,267 $513 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $1.46 Million - $1.62 Million
6,675 Added 0.3%
2,205,437 $533 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $50 Million - $57.3 Million
251,597 Added 12.92%
2,198,762 $495 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $53.1 Million - $62.2 Million
249,959 Added 14.73%
1,947,165 $414 Million
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $26.5 Million - $29.4 Million
-113,277 Reduced 6.26%
1,697,206 $414 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $13.5 Million - $15.7 Million
-60,675 Reduced 3.24%
1,810,483 $450 Million
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $7.73 Million - $9.2 Million
-35,721 Reduced 1.87%
1,871,158 $430 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $60.3 Million - $67.1 Million
257,069 Added 15.58%
1,906,879 $485 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $47 Million - $57.6 Million
237,383 Added 16.81%
1,649,810 $389 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $41 Million - $54.4 Million
225,088 Added 18.96%
1,412,427 $286 Million
Q4 2019

Feb 18, 2020

SELL
$189.21 - $243.2 $10.1 Million - $13 Million
-53,585 Reduced 4.32%
1,187,339 $286 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $12.5 Million - $15 Million
71,682 Added 6.13%
1,240,924 $240 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $9.11 Million - $10.7 Million
54,632 Added 4.9%
1,169,242 $215 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $1.88 Million - $2.12 Million
10,376 Added 0.94%
1,114,610 $212 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $4.28 Million - $4.99 Million
-23,968 Reduced 2.12%
1,104,234 $215 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $3.99 Million - $4.49 Million
-21,516 Reduced 1.87%
1,128,202 $234 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $2.72 Million - $3.05 Million
-16,359 Reduced 1.4%
1,149,718 $212 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $58.8 Million - $68.8 Million
-347,307 Reduced 22.95%
1,166,077 $199 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $8.54 Million - $9.54 Million
50,568 Added 3.46%
1,513,384 $263 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $245 Million - $279 Million
1,462,816
1,462,816 $273 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.